Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity
NCT ID: NCT06260579
Last Updated: 2024-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
147 participants
INTERVENTIONAL
2022-11-14
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Trial in Chronic Kidney Disease
NCT01462097
Adapted Physical Activity Effect on Aerobic Function and in Patients in Pre Liver Transplantation
NCT02567591
Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease
NCT02112825
Effects of Different Exercise Training Programs in CKD 4-5
NCT02041156
Exercise and Vascular Function in Chronic Kidney Disease
NCT02050035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This multicentre two-phased RCT comprehends a six-month exercise intervention at different exercise intensities, followed by an implementation strategy bundle promoting a physically active lifestyle. A total of 147 adult de novo kidney transplant recipients from two independent Belgian transplant centres will be randomly allocated to either 6 months of home-based exercise training consisting of muscle flexibility and postural stability exercises (low intensity training, LIT, n=49), moderate-intensity aerobic and strength training (moderate intensity training, MIT, n=49), or moderate- and high-intensity aerobic and strength training (moderate- and high-intensity training, MHIT, n=49). MIT will participate in moderate-intensity aerobic training on a stationary bicycle thrice a week and moderate-intensity strength training sessions twice a week. During the initial three months of the exercise intervention MHIT will participate in the same training program as MIT. In the final three months of the training intervention, MHIT will participate in high-intensity aerobic training on a stationary bicycle thrice a week and moderate-intensity strength training twice a week.
Following the six-month exercise training intervention, MIT and MHIT, but not LIT, will receive an individualized activity intervention aiming for long-term physical activity maintenance; using motivational interviewing techniques, co-creation of an action plan adapted to the patients' preferences, goal-setting, gradually decreasing follow-up prompts over time, and self-monitoring of physical activity behaviour. The training and physical activity interventions are initiated 3 and 9 months after transplantation, respectively. Study participants will be followed-up till 2 years after transplantation.
The investigators hypothesize that the study intervention will improve the primary outcome cardiorespiratory fitness, assessed as peak oxygen uptake, at 9 months posttransplant. Secondary outcomes include muscle fitness, motor fitness, body composition, cardiovascular health, gut microbiome characteristics, health-related quality of life, safety, cost-effectiveness, and implementation outcomes at six, nine, 12 and 24 months posttransplant. The role of training intensity and the role of baseline gut microbiome characteristics as predictor of individuals' training response will be explored.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low intensity training (LIT)
6 months of low-intensity flexibility and balance exercises, not followed by a formal physical activity intervention
Exercise/physical activity
personalized exercise training and physical activity program
Moderate-intensity training (MIT)
6 months of exercise intervention (moderate intensity), followed by a co-developed physical activity intervention
Exercise/physical activity
personalized exercise training and physical activity program
Moderate- and high-intensity training group (MHIT)
6 months of exercise intervention (moderate-intensity followed by high-intensity), followed by a co-developed physical activity intervention
Exercise/physical activity
personalized exercise training and physical activity program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise/physical activity
personalized exercise training and physical activity program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncontrolled hypertension
* Uncontrolled diabetes, defined as HbA1c ≥ 9%
* Musculoskeletal disorders not allowing physical training on a cycle ergometer, or any other medical reasons by the physician considered to be a contraindication for moderate or high-intensity physical exercise
* Multi-organ transplantation
* Ongoing treatment for malignancies
* Unable to understand Dutch
* No access to smartphone and/or computer with internet access
* Severe pulmonary disease defined as either forced vital capacity (FVC) \<50%, one-second value (FEV1) \<50%, or a diffusing capacity for carbon monoxide (DLCO) \<40% that excludes all serious underlying respiratory disease (pulmonary fibrosis, COPD GOLD II-IV, PAH).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Ghent
OTHER
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amaryllis Van Craenenbroeck
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amaryllis Van Craenenbroeck, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Patrick Calders, PhD
Role: PRINCIPAL_INVESTIGATOR
University Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Ghent
Ghent, , Belgium
UZ Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Calders Patrick, PhD
Role: primary
Amaryllis Van Craenenbroeck, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S006722N
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
S-number 66153
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.